55 results
8-K
EX-99.1
ZLAB
Zai Lab Limited
8 May 24
Zai Lab Announces First Quarter 2024
4:09pm
with community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI) in the first quarter of 2023
8-K
EX-99.1
ZLAB
Zai Lab Limited
27 Feb 24
Zai Lab Announces Full-Year 2023
4:12pm
was driven by the initial inclusion of NUZYRA (IV formulation) for the treatment of adults with community-acquired bacterial pneumonia (CABP
8-K
EX-99.1
xevufo94
30 Jun 23
Zai Lab and argenx Announce Approval of VYVGART® (efgartigimod alfa injection) for Generalized Myasthenia Gravis in China
4:18pm
8-K
EX-99.1
knlk3xy11y2u l5
9 Nov 22
Zai Lab Announces Third Quarter 2022
4:13pm
8-K
EX-99.1
l8fdpbnf2f1 35
9 Aug 22
Zai Lab Announces Second Quarter 2022
12:00am
8-K
EX-99.1
b1lek83mu 3flee
31 May 22
Other Events
8:51am
8-K
EX-99.1
f1uqbfjnedszoqfsml
10 May 22
Zai Lab Announces First Quarter 2022
4:10pm
8-K
EX-99.1
zvmcjzzwv7bwz5cca2
1 Mar 22
Results of Operations and Financial Condition
4:17pm